HUMA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Humacyte Inc

Watchlist Manager

Watchlist

Price: 0.665 USD -4% Market Closed

Market Cap: $179.3m

	Humacyte Inc NASDAQ:HUMA	US
B	Bank of America Corp SGO:BAC	US
	IGEA Pharma NV SIX:IGPH	NL
	Liberty Defense Holdings Ltd XTSX:SCAN	CA
T	Teera-Mongkol Industry PCL SET:TMI	TH
C	Crown Holdings Inc F:CWN	US
O	Osaka Gas Co Ltd F:OSA	JP
	SOL SpA MIL:SOL	IT
	Freeman Gold Corp XTSX:FMAN	CA
T	Tung Ho Steel Enterprise Corp TWSE:2006	TW
	WASGAU Produktions & Handels AG F:MSH	DE
E	Estee Lauder Companies Inc F:ELAA	US

Profitability Summary

Humacyte Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-495%

Negative 3Y Average Gross Margin

-193%

Negative Operating Margin

-6 291%

Negative 3Y Average Operating Margin

-10 000%

Operating Margin is Increasing

-311 767% > -6 291%

Negative Net Margin

-4 561%

Negative 3Y Average Net Margin

-6 007%

Net Margin is Increasing

-295 600% > -4 561%

Negative Free Cash Flow Margin

-4 600%

Negative 3Y Average Free Cash Flow Margin

-9 022%

Free Cash Flow Margin is Increasing

-265 100% > -4 600%

Negative ROE

-548%

Positive 3Y Average ROE

Negative 3Y Average ROIC

-177%

ROIC is Increasing

-176% > -143%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.